The Cardiovascular Risk Associated with the Use of Long Acting Bronchodilators

It seems the pendulum is always swinging back and forth with the management of COPD. Few years ago, we have pulled away from the use of high dose inhaled corticosteroids when we found its association with increased risk of pneumonia and related mortalities. Here’s my post on this topic. And thus, the treatment strategy has shifted to using more long acting bronchodilators. These bronchodilators include LABA (long acting beta agonist) and LAMA (long acting muscarinic antagonist).

Continue reading The Cardiovascular Risk Associated with the Use of Long Acting Bronchodilators

Advertisements

Unintended Consequences of OHIP Plus

With the OHIP Plus finally kicking in, I wonder if there have been any unintended consequences that we are just starting to realize. Many have argued it is a political move from the Liberal party to secure a “sure win” in the upcoming election. Others may see it as a step toward a Universal Pharmacare in Canada.  One way or another, its intention is to allow all children and youth under the age of 25 in Ontario to have access to prescription medications without any barriers.

Continue reading Unintended Consequences of OHIP Plus

Pharmacological Treatment for Alcohol Use Disorder

The American Psychiatry Association has just released new practice guidelines for the pharmacological treatment of patients with alcohol use disorder. For the full guidelines, click here.  In this guideline, the use of these 5 agents have been discussed: naltrexone, acamprosate, disulfiram, topiramate and gabapentin.

Continue reading Pharmacological Treatment for Alcohol Use Disorder

Drug Shortage – A Request for Further Research

I have ranted about drug shortages in the past. It is extremely frustrating that medications go on drug shortage with little warning, or when drug shortages occur, simple modification of the therapy isn’t an option.

Continue reading Drug Shortage – A Request for Further Research

Our Opioid Crisis is perhaps a Side Effect of Our Mental Health Crisis

There is a lot of money invested to address our current opioid crisis. We discuss an opioid strategy and implement measures at various levels.  We distribute naloxone kits through our community pharmacies, we provide support through academic detailing services at physicians’ offices and we increase awareness of the risks and harm with long term opioid use in public education campaigns. On many levels, all these activities are addressing our ongoing opioid crisis. But if we dig further, we are also looking at our mental health crisis that desperately needs more attention too.

Continue reading Our Opioid Crisis is perhaps a Side Effect of Our Mental Health Crisis

New Year’s Resolution: Looking Beyond the Script

Happy New Year! As we begin the year of 2018, there are few things that I want to work on professionally.  But the main mission is to focus on delivering values beyond the script.

Continue reading New Year’s Resolution: Looking Beyond the Script